These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 9699654

  • 21. Effects of breast cancer resistance protein inhibitors and pharmaceutical excipients on decreasing gastrointestinal toxicity of camptothecin analogs.
    Zhang XX, Pan WS, Gan L, Zhu CL, Gan Y.
    Acta Pharmacol Sin; 2008 Nov; 29(11):1391-8. PubMed ID: 18954535
    [Abstract] [Full Text] [Related]

  • 22. Preventive effects of Hange-shashin-to on irinotecan hydrochloride-caused diarrhea and its relevance to the colonic prostaglandin E2 and water absorption in the rat.
    Kase Y, Hayakawa T, Aburada M, Komatsu Y, Kamataki T.
    Jpn J Pharmacol; 1997 Dec; 75(4):407-13. PubMed ID: 9469647
    [Abstract] [Full Text] [Related]

  • 23. A mechanistic study on reduced toxicity of irinotecan by coadministered thalidomide, a tumor necrosis factor-alpha inhibitor.
    Yang XX, Hu ZP, Xu AL, Duan W, Zhu YZ, Huang M, Sheu FS, Zhang Q, Bian JS, Chan E, Li X, Wang JC, Zhou SF.
    J Pharmacol Exp Ther; 2006 Oct; 319(1):82-104. PubMed ID: 16815871
    [Abstract] [Full Text] [Related]

  • 24. Prophylactic ciprofloxacin treatment prevented high mortality, and modified systemic and intestinal immune function in tumour-bearing rats receiving dose-intensive CPT-11 chemotherapy.
    Xue H, Field CJ, Sawyer MB, Dieleman LA, Baracos VE.
    Br J Cancer; 2009 May 19; 100(10):1581-8. PubMed ID: 19401694
    [Abstract] [Full Text] [Related]

  • 25. Alleviation of side effects induced by irinotecan hydrochloride (CPT-11) in rats by intravenous infusion.
    Kurita A, Kado S, Kaneda N, Onoue M, Hashimoto S, Yokokura T.
    Cancer Chemother Pharmacol; 2003 Nov 19; 52(5):349-60. PubMed ID: 12904895
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Prevention of irinotecan (CPT-11)-induced diarrhea by oral alkalization combined with control of defecation in cancer patients.
    Takeda Y, Kobayashi K, Akiyama Y, Soma T, Handa S, Kudoh S, Kudo K.
    Int J Cancer; 2001 Apr 15; 92(2):269-75. PubMed ID: 11291056
    [Abstract] [Full Text] [Related]

  • 29. Phase II study of activated charcoal to prevent irinotecan-induced diarrhea.
    Michael M, Brittain M, Nagai J, Feld R, Hedley D, Oza A, Siu L, Moore MJ.
    J Clin Oncol; 2004 Nov 01; 22(21):4410-7. PubMed ID: 15514383
    [Abstract] [Full Text] [Related]

  • 30. Phase I and pharmacological study of the novel topoisomerase I inhibitor 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) administered as a ninety-minute infusion every 3 weeks.
    Rowinsky EK, Grochow LB, Ettinger DS, Sartorius SE, Lubejko BG, Chen TL, Rock MK, Donehower RC.
    Cancer Res; 1994 Jan 15; 54(2):427-36. PubMed ID: 8275479
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Inhibition of poly(ADP-ribose) polymerase prevents irinotecan-induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma.
    Tentori L, Leonetti C, Scarsella M, Muzi A, Mazzon E, Vergati M, Forini O, Lapidus R, Xu W, Dorio AS, Zhang J, Cuzzocrea S, Graziani G.
    FASEB J; 2006 Aug 15; 20(10):1709-11. PubMed ID: 16809434
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Fish oil supplementation enhanced CPT-11 (irinotecan) efficacy against MCF7 breast carcinoma xenografts and ameliorated intestinal side-effects.
    Hardman WE, Moyer MP, Cameron IL.
    Br J Cancer; 1999 Oct 15; 81(3):440-8. PubMed ID: 10507768
    [Abstract] [Full Text] [Related]

  • 35. St. John's Wort modulates the toxicities and pharmacokinetics of CPT-11 (irinotecan) in rats.
    Hu Z, Yang X, Ho PC, Chan E, Chan SY, Xu C, Li X, Zhu YZ, Duan W, Chen X, Huang M, Yang H, Zhou S.
    Pharm Res; 2005 Jun 15; 22(6):902-14. PubMed ID: 15948034
    [Abstract] [Full Text] [Related]

  • 36. Protective effects of kampo medicines and baicalin against intestinal toxicity of a new anticancer camptothecin derivative, irinotecan hydrochloride (CPT-11), in rats.
    Takasuna K, Kasai Y, Kitano Y, Mori K, Kobayashi R, Hagiwara T, Kakihata K, Hirohashi M, Nomura M, Nagai E.
    Jpn J Cancer Res; 1995 Oct 15; 86(10):978-84. PubMed ID: 7493918
    [Abstract] [Full Text] [Related]

  • 37. Traditional Chinese medicine Gegen Qinlian decoction ameliorates irinotecan chemotherapy-induced gut toxicity in mice.
    Wu Y, Wang D, Yang X, Fu C, Zou L, Zhang J.
    Biomed Pharmacother; 2019 Jan 15; 109():2252-2261. PubMed ID: 30551482
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.